Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 3/2024

Open Access 01-03-2024 | Metastasis | Research

Development of a nomogram to predict the prognosis of patients with secondary bone tumors in the intensive care unit: a retrospective analysis based on the MIMIC IV database

Authors: Weikang Li, Jinliang Li, Jinkui Cai

Published in: Journal of Cancer Research and Clinical Oncology | Issue 3/2024

Login to get access

Abstract

Purpose

The present study aimed to develop a nomogram to predict the prognosis of patients with secondary bone tumors in the intensive care unit to facilitate risk stratification and treatment planning.

Methods

We used the MIMIC IV 2.0 (the Medical Information Mart for Intensive Care IV) to retrieve patients with secondary bone tumors as a study cohort. To evaluate the predictive ability of each characteristic on patient mortality, stepwise Cox regression was used to screen variables, and the selected variables were included in the final Cox proportional hazard model. Finally, the performance of the model was tested using the decision curve, calibration curve, and receiver operating characteristic (ROC) curve.

Results

A total of 1028 patients were enrolled after excluding cases with missing information. In the training cohort, albumin, APSIII (Acute Physiology Score III), chemotherapy, lactate, chloride, hepatic metastases, respiratory failure, SAPSII (Simplified Acute Physiology Score II), and total protein were identified as independent risk factors for patient death and then incorporated into the final model. The model showed good and robust prediction performance.

Conclusion

We developed a nomogram prognostic model for patients with secondary bone tumors in the intensive care unit, which provides effective survival prediction information.
Literature
go back to reference Abdelazeem B, Abbas KS, Rao DN, Tariq R, Wahab A (2022) Incidence and comparative prognosis of cancers with metastasis to noncommon sites: a population-based study. Medicine 101(29):e29743CrossRefPubMedPubMedCentral Abdelazeem B, Abbas KS, Rao DN, Tariq R, Wahab A (2022) Incidence and comparative prognosis of cancers with metastasis to noncommon sites: a population-based study. Medicine 101(29):e29743CrossRefPubMedPubMedCentral
go back to reference Fornetti J, Welm AL, Stewart SA (2018) Understanding the bone in cancer metastasis. J Bone Miner Res 33(12):2099–2113CrossRefPubMed Fornetti J, Welm AL, Stewart SA (2018) Understanding the bone in cancer metastasis. J Bone Miner Res 33(12):2099–2113CrossRefPubMed
go back to reference Guo W, Tang X, Yang Y, Ji T (2008) Surgical treatment and outcome of pelvic metastases. Zhonghua Wai Ke Za Zhi [chinese Journal of Surgery] 46(12):891–894PubMed Guo W, Tang X, Yang Y, Ji T (2008) Surgical treatment and outcome of pelvic metastases. Zhonghua Wai Ke Za Zhi [chinese Journal of Surgery] 46(12):891–894PubMed
go back to reference Liu FT, Qiu C, Luo HL, Zhang Y, Xia GF, Hao TF, Zhu PQ (2016) The association of HOTAIR expression with clinicopathological features and prognosis in gastric cancer patients. Panminerva Med 58(2):167–174PubMed Liu FT, Qiu C, Luo HL, Zhang Y, Xia GF, Hao TF, Zhu PQ (2016) The association of HOTAIR expression with clinicopathological features and prognosis in gastric cancer patients. Panminerva Med 58(2):167–174PubMed
go back to reference Mao Q, Xia W, Dong G, Chen S, Wang A, Jin G, Jiang F, Xu L (2018) A nomogram to predict the survival of stage IIIA-N2 non–small cell lung cancer after surgery. J Thoracic Cardiovasc Surg 155(4):1784–1792CrossRef Mao Q, Xia W, Dong G, Chen S, Wang A, Jin G, Jiang F, Xu L (2018) A nomogram to predict the survival of stage IIIA-N2 non–small cell lung cancer after surgery. J Thoracic Cardiovasc Surg 155(4):1784–1792CrossRef
go back to reference Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Hutterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Muhlebach S, Oldervoll L, Ravasco P, Solheim TS, Strasser F, de van der Schueren M, Preiser JC, Bischoff SC (2021) ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr 40(5):2898–2913. https://doi.org/10.1016/j.clnu.2021.02.005CrossRefPubMed Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Hutterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Muhlebach S, Oldervoll L, Ravasco P, Solheim TS, Strasser F, de van der Schueren M, Preiser JC, Bischoff SC (2021) ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr 40(5):2898–2913. https://​doi.​org/​10.​1016/​j.​clnu.​2021.​02.​005CrossRefPubMed
go back to reference Sheinenzon A, Shehadeh M, Michelis R, Shaoul E, Ronen O (2021) Serum albumin levels and inflammation. Int J Biol Macromol 184:857–862CrossRefPubMed Sheinenzon A, Shehadeh M, Michelis R, Shaoul E, Ronen O (2021) Serum albumin levels and inflammation. Int J Biol Macromol 184:857–862CrossRefPubMed
go back to reference Soares M, Caruso P, Silva E, Teles JM, Lobo SM, Friedman G, Dal Pizzol F, Mello PV, Bozza FA, Silva UV (2010) Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Crit Care Med 38(1):9–15CrossRefPubMed Soares M, Caruso P, Silva E, Teles JM, Lobo SM, Friedman G, Dal Pizzol F, Mello PV, Bozza FA, Silva UV (2010) Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Crit Care Med 38(1):9–15CrossRefPubMed
go back to reference Teshima T, Chatani M, Inoue T, Hirokawa Y, Wadasaki K, Kasiwado K, Kagemoto M, Katsuta S, Honke Y, Koyama T et al (1990) Prognostic factors for patients with osseous metastasis: a multi-institutional prospective study. Strahlentherapie Und Onkologie: Organ Der Deutschen Rontgengesellschaft [et Al] 166(6):387–391 Teshima T, Chatani M, Inoue T, Hirokawa Y, Wadasaki K, Kasiwado K, Kagemoto M, Katsuta S, Honke Y, Koyama T et al (1990) Prognostic factors for patients with osseous metastasis: a multi-institutional prospective study. Strahlentherapie Und Onkologie: Organ Der Deutschen Rontgengesellschaft [et Al] 166(6):387–391
go back to reference Zhai Y, Yao X, Qi Y, Gao J, Chen Y, Wang X, Wu F, Zhao Z (2021) Elevated serum chloride levels contribute to a poor prognosis in patients with IgA nephropathy. J Immunol Res 2021:1CrossRef Zhai Y, Yao X, Qi Y, Gao J, Chen Y, Wang X, Wu F, Zhao Z (2021) Elevated serum chloride levels contribute to a poor prognosis in patients with IgA nephropathy. J Immunol Res 2021:1CrossRef
Metadata
Title
Development of a nomogram to predict the prognosis of patients with secondary bone tumors in the intensive care unit: a retrospective analysis based on the MIMIC IV database
Authors
Weikang Li
Jinliang Li
Jinkui Cai
Publication date
01-03-2024
Publisher
Springer Berlin Heidelberg
Keyword
Metastasis
Published in
Journal of Cancer Research and Clinical Oncology / Issue 3/2024
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-024-05667-9

Other articles of this Issue 3/2024

Journal of Cancer Research and Clinical Oncology 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine